Leading Radiology Forward

Strong Performance as Volumes Have Rebounded from COVID-19 320 270 220 2019 Quarterly Net Revenue $293 170 Q3'19 2020 Quarterly Net Revenue $309 $301 $292 $282 $191 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 2020 Quarterly Adj. EBITDA $47 $51 $46 2019 Quarterly Adj. EBITDA ($ in millions) $41 $23 $20 14.0% 15.6% 15.7% 16.4% 11.9% 7.2% Q3'19 Q4'19 Q1'20 Q2'20 2019 Quarterly Total Leverage 3.96x Q3'19 Q3'20 Q4'20 2020 Quarterly Total Leverage 4.47x 4.40x 3.93x Q4'19 Source: Company Filings and Covenant Compliance Certificate. RadNet. 4.24x 3.84x Q1'20 Q2'20 Q3'20 Q4'20 Denotes period of significant COVID-19 impact Leading Radiology Forward 2

View entire presentation